Home > Boards > US OTC > Medical - Healthcare >

Herborium Group, Inc. (HBRM)

Add HBRM Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 7/31/2014 3:46:54 PM - Followers: 385 - Board type: Free - Posts Today: 0

Energy Restitution: Lasting Energy®

All-Herbal, Caffeine-Free, Sugar-Free, & EGCG-Free, proprietary formula replenishes energy depleted by excessive physical and mental pressure, combats fatigue, decrease stress and promote mental alertness and physical endurance

For Him and Her

Lasting Pleasure® and Lasting Power® are unique, all herbal scientifically developed complex herbal formulas are safe and efficacious alternatives to commonly-prescribed erectile dysfunction (ED) medications or other sexual enhancers.


Herborium Group, Inc.


E- mail inquiries


Investor Relations


Phone: 1 201-849-4431
Fax: 1.866.880.4817
E-mail: CustomerService@Herborium.com




OTC Pink Current Information OTC Pink Current Information


Filings      News

HBRM - Daily Candlesticks

About us

We are a unique provider of alternative and complimentary health care solutions in the U.S and global marketplace. We believe that in addition to traditional Western medicine people have the right to benefit from natural medical alternatives rooted in the wisdom of different cultures, which have accumulated over the centuries. It appears that many of you share this opinion since a recent survey conducted by Reuters indicated that nine out of ten Americans believe that alternative therapies may provide effective solutions to health problems. Recently numerous HMOs are adding this option to their treatment offerings.

Our all natural proprietary medicinal products are carefully selected based on their efficacy and safety records and many of them are accepted as mainstream medicines in their country of origin.

Only products that meet our stringent selection criteria are accepted into our product portfolio.

You can think of Herborium as an Alternative Medicine eHelp-Line since our goal is to provide our customers with targeted high quality solutions for their health needs in a personalized manner.

Our pledge to you is not only to deliver the highest quality all natural medicinal products but also to provide you with up-to date, reliable and complete information addressing your concerns and answering your questions. If we do not have an answer for you-we will find it!.

We want to assist you in making your own decisions. The Health Manuals section of our eHelp-Line allows you to make more informed decisions since we supply our customers with detailed information regarding different diseases and health problems that may benefit from our products as well as important data regarding our product portfolio.

For more information visit http://www.herborium.com/

Product Range

  • AcnEase® Oral , All Natural Acne and Rosacea Treatment
  • AcnEase® Skin Management System® (Masks for Acne Marks/Scars)

Independent reviews of AcnEase:



Sexual Health and Performance
All natural herbal medicinal products targeting the improvement of male and female sexual health and performance.

Energy Restoration
Energy Booster
Lasting Energy® (Energy LL®) "an Herbal Supplement for Energy, Jet-Lag and Hangover


Extended Product Pipeline

  • Liver Activator Series®
  • Rheumatoid Arthritis Product
  • Respiratory Infections Product
  • "Virtual Institute for Alternative and Complementary Medicine" (VIACM)





HERBORIUM is working on several additions to its Product Portfolio. The near term products under development and consideration include:

The Liver Activator Series® Complimentary Liver Support Products that target liver damage resulting from Hepatitis C, Hepatitis B, and Cirrhosis and focus on regaining liver wellness compromised by alcohol, drugs and environmental factors. The leading product that supports both liver wellness and treatment is Liver Rejuvenator®

ProstAid an all natural product focused on Benign Prostate Hyperplasia (BPH) and ProstCare a similar product that targets Prostatitis

CardioVitae® a proprietary, fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies. An enriched extract derived from a Ganoderma lucidium cell line that helps improve and accelerate recovery from cerebrovascular strokes is also under consideration.

The Company focuses on health needs with large market potential as defined by the number of patients and the demonstrated need for more satisfactory medical solutions. Additional priority products identified by Herborium include:

  • Men's Health (Benign Prostate Hyperplasia)
  • Hepatic Disease including Hepatitis and Cirrhosis and Improve hepatic function in patients with chronic liver disease
  • Antibiotic resistant pulmonary infections
  • Rheumatoid Arthritis
  • Cancer
  • Diabetes

Product Distribution Channels

??Domestic Distribution Global Distribution
  • E-Commerce & Affiliates
  • Natural Health Products and Natural Food stores& Chains
  • Specialty High-end Apothecaries,
  • National Upscale Pharmacy chains
  • Healthcare Professional Market
  • SPAs / Health & Beauty
  • Ethnic Markets
  • Wholesale Market
  • E-Commerce & Affiliates
  • Presence in UK & Germany
  • Initial Presence in Japan
  • Market Entry into India & Brazil
  • Healthcare Professional Markets
  • SPAs / Health & Beauty
    Wholesale Market
  • Targeted Markets ( e.g. male market)

Management Profiles

Agnes P. Olszewski, Ph.D. MBA; Founder, President, CEO




Dr. Olszewski, co-founder of Herborium, has over 20 years experience in business strategy, strategic marketing management and international business. She holds an MA and Ph.D. degrees from Warsaw University, Poland, and an MBA from Fordham University, New York City. Dr. Olszewski has been a consultant and a team leader on strategic management and competitive marketing strategies for leading American corporations as well as foreign companies and institutions. In her capacity as an international consultant she had lead multicultural negotiations and managed diverse teams of professionals in the USA, Asia and Europe. She has also been responsible for developing and implementing business and marketing strategies in the US and foreign markets.

Dr. Olszewski's client list includes: AT&T, Johnson & Johnson, Nynex Communications, Unigene Laboratories Inc., Polish Airlines "LOT", Ministry Of Foreign Trade and Economic Collaboration of PRC, UNDP, Graphica Inc. amongst others. She has also been a Small Business Advisor and the Member of the Global Round Table for the State of New Jersey. Dr. Olszewski has been conducting business in China for nearly 20 years.

After the collapse of communism in Central Europe, Dr. Olszewski formed A&T Global Marketing Inc., one of the first consulting firms in the US focusing on the transfer of western management and financial know-how into transitional economies. The company was also involved in advising American corporations on entry strategies into the emerging markets of Europe and Asia. Dr. Olszewski has successfully led the efforts to form Joint Ventures in Poland, China and France. She was a President and CEO of G.O. International, Inc., that she cofounded with Dr. James P. Gilligan, a consulting firm specializing in business strategies for pharmaceutical industry and global technology transfer. G.O. International, Inc. merged with Herborium, Inc. in June 2002.

Prior to starting Herborium, Dr. Olszewski was Director of The Institute for International Business and Director of the MSIB Program at SetonHallUniversity where she is presently a Professor of Marketing and International Business. Dr. Olszewski is the author of over 100 publications and presentations in the US and abroad. She is a Member of The Women's Presidents Organization, an Executive Member of the American Marketing Association, Member of the Academy of International Business, AmericanAcademy of Management, and the International Platform Association. Dr. Olszewski is a recipient of the Valley Forge Foundation National Economic Excellence Award and a recipient of the International Business Award of the State of New Jersey.


James P. Gilligan, Ph.D. MSIB; Co- Founder, Chief Operating Officer


Dr. James Gilligan, a co-founder of Herborium, has over 25 years experience in the pharmaceutical and biotechnology industry, and over 10 years of business experience in China. Dr. Gilligan received his Ph.D. in Pharmacology and Toxicology from the University of Connecticut, during which time he completed a special research fellowship at the Cleveland Clinic Atherosclerosis Research Unit.

He performed his post-doctoral training at the Roche Institute of Molecular Biology. Dr. Gilligan is author or co-author of 15 US patents as well as multiple PCT patents and the author of numerous scientific publications. He also received a MS in International Business from SetonHallUniversity.

Dr. Gilligan is Vice President of Product Development at Unigene Laboratories Inc. Fairfield, NJ, a biopharmaceutical company. He was a founding member of Unigene in 1981 and participated in the design of its R&D facility in 1983 and the cGMP biotechnology manufacturing facility in 1993. His responsibilities have included coordination of all US and international pre-clinical research, toxicology, and regulatory filings as well as design and management of clinical studies. He was an integral part of the team that successfully registered the first "generic" biotechnology product in the EU via a centralized submission. Dr. Gilligan was responsible for coordinating with Warner Lambert (Pfizer) the oral salmon calcitonin program for the treatment and prevention of osteoporosis.

He was also responsible for the US program to register and license Fortical® Nasal Spray, obtain the Company's first NDA approval, as well as identifying new applications for Unigene's technology and negotiations with prospective partners.


Dr. Aihua Qi Vice President, Traditional Chinese Medicine

Dr. Aihua Qi was among the first generation of China' medical experts following the founding of the People's Republic of China, who received eight years of interdisciplinary training in both Western medicine and Traditional Chinese Medicine (TCM). Dr. Qi's professional experience covers the full spectrum of healthcare including: teaching, research and practice in various renowned academic institutions, hospitals and clinics in the capacity of professor, pharmacist, researcher, and physician. She served in leadership positions in a number of projects focusing on: hepatitis, diabetes, anti-frostbite and cardiovascular diseases at leading Government and MilitaryHospitals.

Dr. Qi combined her medical training with an entrepreneurship in the late 1980s when she established and operated private medical clinics in the United States and Hong Kong. Over a period of twenty years in addition to private practice she also developed a number of safe and effective drugs based on unique herbal formulations, representing the innovative combination of western methodology and traditional Chinese medicinal theories. In particular she developed novel herbal medicines that improved liver function in patients with chronic hepatic disease.

Dr. Qi has also developed a formula that targeted dermatological problems related to acne and Rosacea; this product was recognized by the Chinese Ministry of Health as a drug and was granted an NDA. Her outstanding contributions to the field of medicine brought her scientific recognitions as the honorary president of Liaoning Traditional Chinese Medicine Institute, adjunct professor at the 302 Hospital of the Chinese People's Liberation Army, editor to the Chinese Journal of Infectious Diseases, and Council Member to the Liaoning Traditional Chinese Medicine Society, among others.

Dr. Qi is a graduate of AnshanMedicalUniversity where she completed her degree in Western Medicine (1967) and a graduate of Liaoning Traditional Chinese Medical Academic Institute where she specialized in Chinese Medicine.


John E. Donahue, Controller/SEC Advisor

25+ years experience corporate finance, M&A, public accounting


Lawrence Woo, Director; Asia Business Advisor

Past President Pfizer Greater China , President Wyeth Pharmaceutical China

Sir Roger Jones (OBE), Director; UK & EU Advisor

Sir Roger Jones, a business entrepreneur, and a former Governor of the BBC and former Chairman of Welsh Development Agency, is Chair to the Panel of the National Assembly for Wales. He is also a past Chairman of the Institute of Directors Wales, and Chairman of the Committee for Wales of the National Trust.  Sir Roger is currently the Pro-Chancellor and holds the Chair of Council at Swansea University. He was appointed an OBE in 1996 for his services to the pharmaceutical industry and was knighted in the 2005 New Year honours' list. He is also The Republic of Estonia's first honorary consul in Wales.

Dr. J. Thomas August, MD, Clinical Advisor

Dr. J. Thomas August is a Distinguished Professor at the Department of pharmacology at Johns Hopkins University School of Medicine and is the inventor of the LAMP Technology. Dr. August started his career with a medical degree from Stanford University and trained in medicine as the resident house physician to Sir Stanley Davidson at the University of Edinburgh. His early academic appointments included Assistant Professor of Medicine, Stanford University School of Medicine; Associate Professor of Medicine assigned to Microbiology, New York University School of Medicine and Chairman, Department of Molecular Biology and Director, Division of Biological Sciences, Albert Einstein College of Medicine.

In 1976 Dr. August was appointed Director of Pharmacology and Experimental Therapeutics at Johns Hopkins University School of Medicine. The focus of August research at Johns Hopkins included the use of monoclonal antibodies to identify cellular proteins including discovery in 1980 of a family of lysosome associated membrane proteins (and). Several laboratories with antibodies to LAMP showed its colocalization with the major histocompatibility class II (MHC-II) proteins that acts to deliver the antigenic peptide units of proteins to helper T cells. This finding prompted the development of DNA vaccines encoding antigen proteins as LAMP chimeras areas in order to target and enhance the delivery of the antigens to the helper T cell pathway. This research continues novel epitope-based vaccines to several viral pathogens including HIV, dengue, influenza, West Nile and others. Dr. August honors include appointments as a Markley Scholar in Medical Sciences; Fellow, John Simon Guggenheim Memorial Foundation; Fellow, Balliol College at Oxford University, Adjunct Professor of Medicine, National University of Singapore and an R37 NIAID Merit Award for HIV vaccine research.

Transfer Agent

Colonial Stock Transfer Co., Inc.

Company Name Colonial Stock Transfer Co., Inc.
Location 66 Exchange Place
Salt Lake City, UT 84111
Phone 801-355-5740
Website http://www.colonialstock.com
E-mail Address info@colonialstock.com

(NOTE: Colonial Stock Transfer's policy is not to give out the share structure of any of the companies they represent.)   :(

Share Structure
Market Value1 $350,316 a/o Oct 24, 2013
Shares Outstanding 875,788,844 a/o Aug 31, 2013
Float Not Available
Authorized Shares 1,950,000,000 a/o Aug 31, 2013
Par Value 0.001
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
HBRM News: Herborium Group's 2014 First Seven Months Sales Surpasses 2013 Annual Sales. 07/24/2014 08:27:10 AM
HBRM News: Herborium Group's Second Quarter Sales Grows over 132% 07/17/2014 08:30:00 AM
HBRM News: Herborium Group First Quarter Sales Grows 45%; Debt reduced by $1Million 03/27/2014 08:15:00 AM
HBRM News: Herborium Group Exceeds Sales Expectations for 2013 03/10/2014 08:45:00 AM
#49768   Sorry, I meant *buy big again. I Fnkychld 07/31/14 03:46:54 PM
#49767   Huh, seems with the 5.6M trade vol. the wharphrat 07/31/14 01:26:20 PM
#49766   If it goes back to 0.01 I will Fnkychld 07/31/14 10:51:41 AM
#49765   Thats it. Ease on down to .01 or Randy1111 07/31/14 09:57:01 AM
#49764   nice dump fest, hope people took profits out... curiousbuild 07/30/14 07:44:28 PM
#49763   Not just a day trader. A swing findit 07/30/14 04:46:06 PM
#49762   Stock is still in good shape. People Fnkychld 07/30/14 03:48:22 PM
#49761   Good luck with your trade.... from your previous dc_dude 07/30/14 02:58:08 PM
#49760   thanks for your reply. From the sound findit 07/30/14 02:54:00 PM
#49759   I consider the fluffy PR about the sales dc_dude 07/30/14 01:56:02 PM
#49758   As I said, some made good getting money pual 07/30/14 01:20:44 PM
#49757   Oh, that's rich!!! FMFYMF! ipulator_man 07/30/14 01:19:20 PM
#49756   Should run up this afternoon a bit. Bids Fnkychld 07/30/14 12:57:37 PM
#49755   I'm sure it'll be fine. I suspect another kickasstimus 07/30/14 12:28:44 PM
#49754   "The pot calling the kettle black".... wharphrat 07/30/14 12:23:04 PM
#49753   Lol. Relax it's just cooling down a bit. Fnkychld 07/30/14 12:00:57 PM
#49752   Honestly did any honest poster herein believe the pual 07/30/14 11:15:14 AM
#49751   §HBRM Coolong-off...Re-entry @ .0462 § ipulator_man 07/30/14 11:13:08 AM
#49750   dc not sure where HBRM will end up findit 07/30/14 10:56:54 AM
#49749   Hope all the longs sold yesterday when this dc_dude 07/30/14 10:41:06 AM
#49748   Get the cheapies! It's on it's way to kickasstimus 07/30/14 10:06:01 AM
#49747   UP UP AND AWAY... WOWZER :) curiousbuild 07/29/14 05:57:24 PM
#49746   Just realized that the former president of Pfizer Fnkychld 07/29/14 05:21:14 PM
#49745   Same to all of you. Good things coming. akvr54 07/29/14 04:02:39 PM
#49744   Great day! Have a good night, see Fnkychld 07/29/14 04:01:11 PM
#49743   Great info - thanks. Fnkychld 07/29/14 03:53:15 PM
#49742   Well, hoping they do! wharphrat 07/29/14 03:51:30 PM
#49741   No I meant management wanting to receive their akvr54 07/29/14 03:43:37 PM
#49740   2.5M 'locked' as in restricted ? wharphrat 07/29/14 03:38:54 PM
#49739   Per the financial - in the quarter ending akvr54 07/29/14 03:36:37 PM
#49738   ..paid 30 cents & probably want much more IMO. wharphrat 07/29/14 03:28:26 PM
#49737   Management paid for their shares at .3 thepoet75 07/29/14 03:21:02 PM
#49736   From my estimates float is less than 10% akvr54 07/29/14 02:45:14 PM
#49735   About 50% of the 4.5M O/S traded so far. wharphrat 07/29/14 02:37:43 PM
#49734   Wise decision. Only the start my fellow Herborium. Fnkychld 07/29/14 02:14:46 PM
#49733   Flush out all the weak hands so we Fnkychld 07/29/14 01:01:15 PM
#49732   wow nice run here!! $HBRM paadaek 07/29/14 12:51:19 PM
#49731   This is just getting started man. In a kickasstimus 07/29/14 12:24:36 PM
#49730   Cannot stand those that panic and hit a thepoet75 07/29/14 12:10:19 PM
#49729   HBRM, amazing run. Bought tons at $0.01, now hondaboost 07/29/14 12:09:59 PM
#49728   §HBRM @ .095!!!§ ipulator_man 07/29/14 12:00:49 PM
#49727   get 'em while they're cheap! kickasstimus 07/29/14 11:57:08 AM
#49726   Holy CRAP! kickasstimus 07/29/14 11:52:25 AM
#49725   Here we go!!!!! Run baby!! ipulator_man 07/29/14 11:52:07 AM
#49724   That's retail and now NITE has over 200k thepoet75 07/29/14 11:50:52 AM
#49723   He's still got about 380K here @ .06 ipulator_man 07/29/14 11:50:08 AM
#49722   Bahaha, that'll teach him to mess with the Herboriums! Fnkychld 07/29/14 11:41:35 AM
#49721   Lol Nite running out of shares to short. thepoet75 07/29/14 11:36:27 AM
#49720   Over 10% of O/S traded so far..float lockin tighter. wharphrat 07/29/14 11:35:00 AM
#49719   Not even worried. It'll hit dimes before the kickasstimus 07/29/14 11:30:44 AM